149 related articles for article (PubMed ID: 28587766)
21. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies.
Maalmi H; Ordóñez-Mena JM; Schöttker B; Brenner H
Eur J Cancer; 2014 May; 50(8):1510-21. PubMed ID: 24582912
[TBL] [Abstract][Full Text] [Related]
22. Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies.
Schöttker B; Ball D; Gellert C; Brenner H
Ageing Res Rev; 2013 Mar; 12(2):708-18. PubMed ID: 22343489
[TBL] [Abstract][Full Text] [Related]
23. Association between Blood 25-Hydroxyvitamin D Levels and Survival in Colorectal Cancer Patients: An Updated Systematic Review and Meta-Analysis.
Maalmi H; Walter V; Jansen L; Boakye D; Schöttker B; Hoffmeister M; Brenner H
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30011816
[TBL] [Abstract][Full Text] [Related]
24. Association of 25-hydroxyvitamin D level with survival outcomes in female breast cancer patients: A meta-analysis.
Li C; Li H; Zhong H; Li X
J Steroid Biochem Mol Biol; 2021 Sep; 212():105947. PubMed ID: 34214604
[TBL] [Abstract][Full Text] [Related]
25. Serum 25-hydroxyvitamin D levels and peripheral neuropathy in patients with type 2 diabetes: a systematic review and meta-analysis.
Lv WS; Zhao WJ; Gong SL; Fang DD; Wang B; Fu ZJ; Yan SL; Wang YG
J Endocrinol Invest; 2015 May; 38(5):513-8. PubMed ID: 25527161
[TBL] [Abstract][Full Text] [Related]
26. Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival.
Yuan C; Qian ZR; Babic A; Morales-Oyarvide V; Rubinson DA; Kraft P; Ng K; Bao Y; Giovannucci EL; Ogino S; Stampfer MJ; Gaziano JM; Sesso HD; Buring JE; Cochrane BB; Chlebowski RT; Snetselaar LG; Manson JE; Fuchs CS; Wolpin BM
J Clin Oncol; 2016 Aug; 34(24):2899-905. PubMed ID: 27325858
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of circulating inflammatory factors in non-small cell lung cancer: a systematic review and meta-analysis.
Liao C; Yu Z; Guo W; Liu Q; Wu Y; Li Y; Bai L
Cancer Biomark; 2014; 14(6):469-81. PubMed ID: 25335739
[TBL] [Abstract][Full Text] [Related]
28. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.
Trépo E; Ouziel R; Pradat P; Momozawa Y; Quertinmont E; Gervy C; Gustot T; Degré D; Vercruysse V; Deltenre P; Verset L; Gulbis B; Franchimont D; Devière J; Lemmers A; Moreno C
J Hepatol; 2013 Aug; 59(2):344-50. PubMed ID: 23557869
[TBL] [Abstract][Full Text] [Related]
29. The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.
Schmutz EA; Zimmermann MB; Rohrmann S
Eur J Nutr; 2016 Feb; 55(1):393-402. PubMed ID: 25701092
[TBL] [Abstract][Full Text] [Related]
30. Effects of Circulating 25(OH)D Status in Advanced Colorectal Cancer Patients Undergoing Chemotherapy: A Systematic Review.
Zeng X; Zhang L; Jia S; Lin T; Liu G; Yue J; Huang X
Anticancer Res; 2021 Dec; 41(12):5903-5912. PubMed ID: 34848444
[TBL] [Abstract][Full Text] [Related]
31. Circulating tumor cells predict survival benefit from chemotherapy in patients with lung cancer.
Wu ZX; Liu Z; Jiang HL; Pan HM; Han WD
Oncotarget; 2016 Oct; 7(41):67586-67596. PubMed ID: 27588489
[TBL] [Abstract][Full Text] [Related]
32. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies.
Ma Y; Zhang P; Wang F; Yang J; Liu Z; Qin H
J Clin Oncol; 2011 Oct; 29(28):3775-82. PubMed ID: 21876081
[TBL] [Abstract][Full Text] [Related]
33. Circulating vitamin D level and mortality in prostate cancer patients: a dose-response meta-analysis.
Song ZY; Yao Q; Zhuo Z; Ma Z; Chen G
Endocr Connect; 2018 Dec; 7(12):R294-R303. PubMed ID: 30352424
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D deficiency is associated with a poor prognosis in advanced non-small cell lung cancer patients treated with platinum-based first-line chemotherapy.
Ma K; Xu W; Wang C; Li B; Su K; Li W
Cancer Biomark; 2017; 18(3):297-303. PubMed ID: 27983538
[TBL] [Abstract][Full Text] [Related]
35. Circulating tumor cells as a potential biomarker in diagnosis of lung cancer: a systematic review and meta-analysis.
Huang H; Shi Y; Huang J; Wang X; Zhang R; Chen H
Clin Respir J; 2018 Feb; 12(2):639-645. PubMed ID: 27778482
[TBL] [Abstract][Full Text] [Related]
36. HE4 expression in lung cancer, a meta-analysis.
Zhong H; Qian Y; Fang S; Yang L; Li L; Gu W
Clin Chim Acta; 2017 Jul; 470():109-114. PubMed ID: 28499820
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D deficiency is associated with the severity of COPD: a systematic review and meta-analysis.
Zhu B; Zhu B; Xiao C; Zheng Z
Int J Chron Obstruct Pulmon Dis; 2015; 10():1907-16. PubMed ID: 26392765
[TBL] [Abstract][Full Text] [Related]
38. Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer.
Heist RS; Zhou W; Wang Z; Liu G; Neuberg D; Su L; Asomaning K; Hollis BW; Lynch TJ; Wain JC; Giovannucci E; Christiani DC
J Clin Oncol; 2008 Dec; 26(34):5596-602. PubMed ID: 18936471
[TBL] [Abstract][Full Text] [Related]
39. Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis.
Tong M; Wang J; Jiang N; Pan H; Li D
PLoS One; 2017; 12(8):e0182282. PubMed ID: 28797050
[TBL] [Abstract][Full Text] [Related]
40. Circulating miR-31 as an effective biomarker for detection and prognosis of human cancer: a meta-analysis.
Ma Y; Chen Y; Lin J; Liu Y; Luo K; Cao Y; Wang T; Jin H; Su Z; Wu H; Chen X; Cheng J
Oncotarget; 2017 Apr; 8(17):28660-28671. PubMed ID: 28404921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
